M.S Life Drug House Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 28-06-2024
- Paid Up Capital ₹ 4.66 M
as on 28-06-2024
- Company Age 24 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.72 Cr
as on 28-06-2024
- Satisfied Charges ₹ 47.26 Cr
as on 28-06-2024
- Revenue 18.90%
(FY 2023)
- Profit 66.36%
(FY 2023)
- Ebitda 44.59%
(FY 2023)
- Net Worth 29.63%
(FY 2023)
- Total Assets 9.91%
(FY 2023)
About M.S Life Drug House
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 4.66 M.
The company currently has active open charges totaling ₹40.72 Cr. The company has closed loans amounting to ₹47.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sudipa Das and Swapan Das serve as directors at the Company.
- CIN/LLPIN
U24231WB2000PTC092372
- Company No.
092372
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at M.S Life Drug House?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapan Das  | Managing Director | 05-Sep-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudipa Das | Director | 05-Sep-2000 | Current |
Financial Performance and Corporate Structure Insights of M.S Life Drug House.
M.S Life Drug House Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.9% increase. The company also saw a substantial improvement in profitability, with a 66.36% increase in profit. The company's net worth Soared by an impressive increase of 29.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M.S Life Drug House?
In 2023, M.S Life Drug House had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sip2life Distilleries Private LimitedActive 11 years 1 monthSudipa Das and Swapan Das are mutual person
- Gsa Surgical & Medicines Private LimitedActive 23 years 10 months
Sudipa Das and Swapan Das are mutual person
- Vishnu Properties & Industries Pvt.Ltd.Active 66 years 7 months
Sudipa Das and Swapan Das are mutual person
- Jai Balaji Procon Private LimitedActive 14 years 2 months
Sudipa Das and Swapan Das are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jan 2024 | ₹6.05 Cr | Open |
Others Creation Date: 08 Oct 2021 | ₹34.67 Cr | Open |
Others Creation Date: 21 Oct 2020 | ₹25.00 Cr | Satisfied |
How Many Employees Work at M.S Life Drug House?
M.S Life Drug House has a workforce of 260 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M.S Life Drug House, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M.S Life Drug House's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
